NCT06394128View on ClinicalTrials.gov

Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2026

Conditions

Cancer-Related FatigueColorectal Cancer

Interventions

DRUG

Cangpo Liujun Prescription

Based on the diagnostic criteria of spleen deficiency and dampness excess syndrome, Cangpo Liujun Prescription could be used to treat cancer-related fatigue in patients with advanced colorectal cancer undergoing second-line chemotherapy.

Trial Locations (1)

310006

RECRUITING

Hangzhou First People' Hospital, Hangzhou

All Listed Sponsors

lead

First People's Hospital of Hangzhou

OTHER